Works matching IS 13406868 AND DT 2016 AND VI 23 AND IP 3


Results: 22
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer.

    Published in:
    Breast Cancer (13406868), 2016, v. 23, n. 3, p. 499, doi. 10.1007/s12282-015-0593-z
    By:
    • Shiba, Eiichi;
    • Yamashita, Hiroko;
    • Kurebayashi, Junichi;
    • Noguchi, Shinzaburo;
    • Iwase, Hirotaka;
    • Ohashi, Yasuo;
    • Sasai, Kiyofumi;
    • Fujimoto, Tsukasa
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22